NM_001134363.3:c.2264G>A
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001134363.3(RBM20):c.2264G>A(p.Arg755His) variant causes a missense change. The variant allele was found at a frequency of 0.0000548 in 1,551,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.2264G>A | p.Arg755His | missense_variant | Exon 9 of 14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.2099G>A | p.Arg700His | missense_variant | Exon 9 of 14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.1880G>A | p.Arg627His | missense_variant | Exon 9 of 14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.1880G>A | p.Arg627His | missense_variant | Exon 9 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000831 AC: 13AN: 156416Hom.: 0 AF XY: 0.000109 AC XY: 9AN XY: 82930
GnomAD4 exome AF: 0.0000529 AC: 74AN: 1399416Hom.: 0 Cov.: 32 AF XY: 0.0000522 AC XY: 36AN XY: 690220
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74490
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The p.R755H variant (also known as c.2264G>A), located in coding exon 9 of the RBM20 gene, results from a G to A substitution at nucleotide position 2264. The arginine at codon 755 is replaced by histidine, an amino acid with highly similar properties. This alteration has been reported in hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) cohorts (Lopes LR et al. Heart, 2015 Feb;101:294-301; Horvat C et al. Genet. Med., 2019 01;21:133-143; Dai J et al. Can J Cardiol, 2021 Nov;37:1751-1759). This alteration was also reported in a control subject (Neoldová M et al. Pharmacogenomics, 2016 Aug;17:1405-14). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Dilated cardiomyopathy 1DD Benign:1
- -
not provided Benign:1
RBM20: BS1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at